Grants awarded

The foundation has awarded, among others, the following grants.

 

In 2024

 

Adjunct Professor Pernilla Dahm Kähler for the project "Optimizing Gynecologic Cancer Surgery - A Path to Precision and Personalized Treatment" aims to improve the treatment and prognosis of gynecologic cancer, with a particular focus on ovarian cancer.

The goal of the project is to use precision medicine to tailor treatment strategies based on the genetic and molecular profiles of individual patients, which could lead to improved survival rates, reduced risk of recurrence, and enhanced quality of life for affected women.

 

In 2023

 

Associate Professor Kristina Lundberg for the project "The Role of Tumor-Infiltrating Immune Cells in New Immuno-Oncological Therapies - Towards the Development of New Treatment Strategies" aims to identify new target structures to initiate an effective immune response against tumor cells.

The goal of the project is to develop antibodies against a new potential target molecule, which could lead to new treatment methods for cancer and thereby increase the survival rate of cancer patients.

 

In 2022

 

Professor Karin Sundfeldt for the project "Mota Ulle i grind! Utveckling av ett screeningverktyg för ovarialcancer (OVACATCH) kommer kraftigt minska dödligheten i sjukdomen”.

The goal with this project is to increase ovarian cancer diagnosis in an early stage to offer a curative treatment. 

 

In 2021

 

Dr Magnus Jakobsson for the project "Early and improved diagnosis of Ovarian cancer".  

The goal with this project is to develop a diagnostic test for detection of ovarian cancer. The project aims to enable diagnosis of ovarian cancer at an early stage when the disease is treatable. 

 

In 2020

 

Professors Carl Borrebaeck at Lund University, George Coukos at University of Lausanne, Douglas Hanahan at Swiss Federal Institute of Technology Lausanne and Kristian Pietras at Lund University for the project ”Advancing Innovative Cancer Therapies”.

The project was awarded a first grant in 2019. This year’s grant refers to continued research within this project.

 

In 2019

 

Professors Carl Borrebaeck at Lund University, George Coukos at University of Lausanne, Douglas Hanahan at Swiss Federal Institute of Technology Lausanne and Kristian Pietras at Lund University for the project ”Advancing Innovative Cancer Therapies”. 

The overall goals of the project are to develop innovative technologies that will enable significant process in personalized cancer therapy, to pursue the development of research tools and methodologies that will allow discovery of new cancer treatments and to continue promoting collaborations between Swiss Cancer Center Leman and Lund. To reach these goals the project will work with advancing antibody and chimeric antigen receptor T-cell therapy for tumors and work with innovative bioengineering technologies. The project will also focus on continuing the successful collaboration in targeting endocrine therapy resistance in luminal tumors and in exploiting new therapeutic vulnerabilities in triple-negative breast cancer. 

 

Skåne University Hospital for the project called ”An inspiring care environment for children and youths at hospitals” under the direction of Head of Unit Ann Elmqvist Fridh.

There is a great need to improve the environment in the often bare care rooms. Studies show a calming effect of animals and nature and through projections of live fish on the walls for example you can activate and distract the children so that their visit is more joyful. The grant covers costs for purchase and installation of projections. 

 

In 2018

 

Centre Hospitalier du Luxembourg, Department General and Minimally Invasive Surgery for the project "Comparative study of prognostic markers in colorectal cancer" Under the supervision of Dr Martine Goergen-Azagra and Silviu-Tiberiu Makkai-Popa.

The aim of the project is to collect, analyse, and compare different factors which have an impact on the cancer tumour's prognosis, with the goal of optimising the treatment of cancer patients.